Can different cancers be prevented using existing drugs?

Treatment of any cancer involves range of chemo-therapies and radio-therapies which have various side effects. Researchers have tried to design new therapies to tackle diseases like gastric and breast cancers . Scientists have now identified existing drugs could be used to treat or even prevent, hereditary stomach and breast cancers.which currently no preventive measures other than surgical removal of the stomach. Breast cancers are also hard to detect by mammography and mastectomies are also undertaken by some carriers. (Read:Cancer in India -- the 10 most common types you should be aware of)

But the new findings, published in the journal Molecular Cancer Therapeutics, suggest that people at genetic risk of these diseases may soon be spared of taking such hard decisions. 'Making such drug treatments a reality would mean delaying or completely avoiding the trauma that high-risk individuals experience by undergoing major preventive surgery at a young age,' said lead researcher Parry Guilford, professor at the University of Otago in New Zealand. (Read:10 ways to change your food habits and prevent cancer )

The researchers found that key genetic mutation underlying the devastating conditions also opens them to attack through drug therapies targeting other cellular mechanisms.The team used genomic screening to search for vulnerabilities in the cancer cells that lack the tumour-suppressor protein E-cadherin.

The genetic mutation that causes this protein to be lost is common in hereditary diffuse gastric and lobular breast cancers. E-cadherin is not a traditional drug target for these forms of cancer because the protein is present in healthy cells but absent in malignant ones. However, professor Guilford and his team predicted that its loss might create other vulnerabilities in these cancer cells and they were proved right. Next, the researchers screened selected drug classes known to interfere with these proteins, and found that early chemoprevention treatments could be developed for people who carry the E-cadherin mutation and as a result are at high risk of gastric and lobular breast cancers.

With inputs from IANS

Image source: Getty Images

---

For more articles on diseases & conditions, visit our diseases & conditions section. For daily free health tips, sign up for our newsletter.